Trials / Completed
CompletedNCT00182169
Evaluation of the Effect of Human Recombinant Growth Hormone in Patients With Advanced Heart Failure
Randomized, Placebo Control, Clinical Trial Evaluating the Effect of Human Recombinant Growth Hormone in Patients With Severe Congestive Heart Failure. The Growth Hormone In Heart Failure Trial (GIFT)
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 80 (planned)
- Sponsor
- Hamilton Health Sciences Corporation · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
Prospective randomized, placebo controlled, clinical trial to evaluate the effect of human growth hormone supplementation compared with placebo to patients with severe heart failure for a duration of 6 months on exercise capacity, heart function and quality of life
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Human recombinant growth hormone |
Timeline
- Start date
- 1997-07-01
- Completion
- 2005-06-01
- First posted
- 2005-09-16
- Last updated
- 2005-09-16
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT00182169. Inclusion in this directory is not an endorsement.